Unifying Vascular Injury and Neurodegeneration: A Mechanistic Continuum in Cerebral Small Vessel Disease and Dementia
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Cerebral small vessel disease (CSVD) drives dementia by worsening neurodegeneration through vascular damage. Our model integrates these factors, identifying new targets for dementia prevention and treatment.
Area Of Science
- Neurology
- Neuroscience
- Vascular Biology
Background
- Cerebral small vessel disease (CSVD) is a primary cause of cognitive impairment and dementia.
- CSVD actively amplifies neurodegeneration via microvascular injury, blood-brain barrier (BBB) disruption, and impaired glymphatic function.
Purpose Of The Study
- To propose the Integrated Vascular-Neurodegenerative Continuum model.
- To elucidate the mechanistic link between vascular pathology and neurodegeneration.
Main Methods
- Synthesizing molecular, imaging, and genetic evidence.
- Reviewing current diagnostic and therapeutic strategies for CSVD and dementia.
- Proposing novel biomarkers and therapeutic agents.
Main Results
- The proposed model integrates chronic hypoperfusion, oxidative stress, and APOE ε4-related endothelial dysfunction.
- Identified advanced imaging techniques (e.g., skeletonized mean diffusivity, BBB leakage quantification) as key diagnostics.
- Highlighted potential therapeutics including cilostazol and allopurinol.
Conclusions
- The Integrated Vascular-Neurodegenerative Continuum offers a unifying framework for cerebrovascular and neurodegenerative research.
- This model supports precision medicine approaches for dementia prevention and treatment.
- Advocates for multimodal diagnostic strategies for improved risk stratification.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...